Otherwise healthy patients who have mild hypertension are being overtreated, according to an analysis published in The BMJ by UMass Medical School family physicians Stephen Martin, MD, and Marcy Boucher, MD.
The Meyers Primary Care Institute at UMass Medical School is one of 10 sites taking part in a $30 million, five-year intervention study to drastically reduce the number of falls in older adults funded by National Institutes of Health and the Patient Centered Outcomes Research Institute.
The Center for Collaborative Research in Fragile X at UMMS, with a $9.5 million NIH grant, will be led by Professor of Molecular Medicine Joel D. Richter, PhD. Fragile X is the most common form of inherited intellectual and developmental disability. It can affect one in about 4,000 males and one in about 6,000 females.
UMass Medical School, the Patrick administration and the Veterans Administration announced plans for a new outpatient clinic for veterans care on the UMMS campus in Worcester.
Victor R. Ambros, PhD, professor of molecular medicine, has been awarded a $3 million 2015 Breakthrough Prize in Life Sciences for his co-discovery of a new world of genetic regulation by microRNAs.
Despite a high skin cancer risk, tanning beds are available on campus or in off-campus housing at nearly half of the nation’s top colleges, and access is frequently discounted or entirely free of charge, according to a new study from Sherry Pagoto at UMass Medical School.
With a $7.5 million grant from the Paul G. Allen Family Foundation, UMass Medical School will lead a team of academic partners to provide a comprehensive relief effort in Liberia, bringing doctors, nurses and training and medical supplies to the Ebola-stricken country.
A team of international scientists led by John Landers, PhD, has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, is associated with the familial form of the neurodegenerative disease, amyotrophic lateral sclerosis.
With a new $7.9 million program project grant from the National Institutes of Health, drug resistance expert Celia Schiffer, PhD, hopes to shift the drug development paradigm by putting resistance first in drug design strategies.
Two UMMS events, the Be Mentally Well community lecture series on Oct. 21 and the first-of-its-kind food addiction conference on Oct. 22, will shed light on the latest science about the biology, diagnosis and treatment of food addiction.